Atlas Trials

Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity

Clinical trial NCT01265849 · COMPLETED

Trial details

NCT number
NCT01265849
Sponsor
CEL-SCI Corporation
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Soft Palate
Start date
2010-12-01
Primary completion
2020-05-15
Enrollment
928

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.